VP

Vastupal Pratapchand Ladhani

Active Director Managing Director DIN 02486864
DIN 02486864 First appointment Feb 1984 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 1984
Shareholding value β€’β€’β€’β€’ Premium profile

About Vastupal Pratapchand Ladhani

Data last updated:

Vastupal Pratapchand Ladhani is a Managing Director at Vikrant Pharmaceuticals Limited (since 1984). The company operates in Pharma.

DIN 02486864
Primary Designation Managing Director
Industry Pharma
First Appointment 17 Feb 1984
Oldest Company Age 42 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vikrant Pharmaceuticals Limited U99999MH1984PLC032190
Managing Director17 Feb 19841984Active

Board colleagues of Vastupal Pratapchand Ladhani

Directorship timeline

Open interactive timeline →
Vikrant Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Vastupal Pratapchand Ladhani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vastupal Pratapchand Ladhani

Vastupal Pratapchand Ladhani currently holds 1 directorship: Vikrant Pharmaceuticals Limited (Managing Director, since 17 Feb 1984).

Vastupal Pratapchand Ladhani was first appointed on 17 Feb 1984 as Managing Director at Vikrant Pharmaceuticals Limited.

The current boards of Vastupal Pratapchand Ladhani's companies include Kamala Ladhani Vastupal (Vikrant Pharmaceuticals Limited), Shruti Neeraj Ladhani (Vikrant Pharmaceuticals Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available